MedPath

Exercise Training in Treating Diastolic Heart Failure

Not Applicable
Withdrawn
Conditions
Heart Failure, Diastolic
Ventricular Dysfunction, Left
Interventions
Behavioral: High intensity endurance exercise
Behavioral: Moderate continuous endurance exercise
Registration Number
NCT02155842
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The purpose of this study is to determine whether endurance exercise of either high or moderate intensity can reverse structural and functional changes of the heart in patients with diastolic heart failure, and to investigate which type of exercise is best in terms of aerobe capacity and quality of life.

The investigators expect that high intensity endurance exercise is superior to moderate intensity endurance exercise.

Detailed Description

This study is a prospective randomized controlled intervention study comparing two active arms. Eligible patients are being sampled consecutively by cardiologists, and randomized to either high or moderate intensity endurance exercise. Endpoints are measured at baseline, 4 weeks and 7 months. The intervention is considered safe, and the study has been approved by the Regional Ethics Committee (REK-midt).

This project has been financially supported by the Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Sedentary lifestyle
  • Normal systolic function left ventricular ejection fraction (LVEF) < 50%
  • New York Heart Association (NYHA) class II or III
  • Diastolic dysfunction (E/é < 15 or E/é 8-15 and N-terminal proBNP > 220pg/ml)
  • Medically stable the last 4 weeks
  • Written informed consent
Exclusion Criteria
  • Other causes of dyspnea than diastolic heart failure
  • Personal preferences or characteristics prohibiting the person from attending inpatient cardiac rehabilitation
  • Not able to perform physical exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High intensity endurance exerciseHigh intensity endurance exerciseFour weeks comprehensive cardiac rehabilitation with moderate volume high intensity endurance exercise, followed by 6 months non-supervised endurance exercise
Moderate continuous endurance exerciseModerate continuous endurance exerciseFour weeks comprehensive cardiac rehabilitation with moderate volume moderate intensity endurance exercise, followed by 6 months non-supervised endurance exercise
Primary Outcome Measures
NameTimeMethod
Change in aerobic capacity measured as oxygen consumptionBaseline and 7 months

Cardiopulmonary exercise test

Secondary Outcome Measures
NameTimeMethod
Arterial function measured as blood-vessel elasticityBaseline to 7 months

Ultrasound

Cardiac function measured as volume, size, efficacyBaseline to 7 months

Ultrasound

Quality of lifeBaseline to 7 months

Self-reported questionnaires

Changes in everyday activity levelBaseline to 7 months

Self-reported questionnaire, diary, activity monitoring device

Change in diastolic filling pressure measured as E/éBaseline to 7 months

Ultrasound

Feasibility, measured as attrition rate and compliance with exerciseBaseline to 7 months
Blood-risk profile, measured as changes in cholesterol, hemoglobin, N terminal-proBNPBaseline to 7 months

Trial Locations

Locations (1)

LHL Klinikkene

🇳🇴

Røros, Norway

© Copyright 2025. All Rights Reserved by MedPath